Volume 114, Issue 1 pp. 169-173

Protein Z in ischaemic stroke

Katrin Kobelt

Katrin Kobelt

Central Haematology Laboratory, Inselspital, University of Bern,

Division of Haematology, Department of Internal Medicine, Kantonsspital Lucerne, and

Search for more papers by this author
Franziska Demarmels Biasiutti

Franziska Demarmels Biasiutti

Central Haematology Laboratory, Inselspital, University of Bern,

Search for more papers by this author
Heinrich P. Mattle

Heinrich P. Mattle

Department of Neurology, Inselspital, University of Bern, Bern, Switzerland

Search for more papers by this author
Bernhard Lämmle

Bernhard Lämmle

Central Haematology Laboratory, Inselspital, University of Bern,

Search for more papers by this author
Walter A. Wuillemin

Walter A. Wuillemin

Central Haematology Laboratory, Inselspital, University of Bern,

Division of Haematology, Department of Internal Medicine, Kantonsspital Lucerne, and

Search for more papers by this author
First published: 12 January 2002
Citations: 48
Walter A. Wuillemin, Division of Haematology, Kantonsspital, CH-6000 Lucerne 16, Switzerland. E-mail: walter. [email protected]

Abstract

Many risk factors associated with ischaemic stroke are known, including high levels of fibrinogen or factor VII. Protein Z is a vitamin K-dependent coagulation factor, which was found to promote the assembly of thrombin with phospholipid vesicles that might promote coagulation. Indeed, a low protein Z level may be associated with a varying bleeding tendency. Therefore, we hypothesized that high protein Z levels could induce a hypercoagulable state and performed a case–control study to investigate a potential association between high protein Z plasma levels and ischaemic stroke. We measured protein Z in plasma samples from 157 patients with stroke of unknown aetiology and 192 control subjects. All patients had survived an ischaemic stroke or transient ischaemic attack (TIA) for at least 2 months. We found an increased relative risk of ischaemic stroke with increasing protein Z levels, with an odds ratio of 4·3 [95% confidence interval (CI): 1·7–11] for protein Z plasma levels ≥ 160%. Excluding patients with a history of venous thromboembolism from the analysis, the same result was obtained (odds ratio 4·2; 95% CI: 1·6–11·2). Using a logistic regression model, this association also remained significant (P = 0·04) after adjustment for established risk factors. Our data indicated that a high plasma level of protein Z is an independent risk factor for ischaemic stroke.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.